Organoids are invaluable preclinical models for studying cancer and offer many advantages over existing human or non-human animal cancer models. These complex, self-organizing microtissues are grown embedded within 3-D extracellular matrix, enabling the formation of complex structures that closely resemble the architecture and physiological functions of organs or tissues. In collaboration with the Human Cancer Models Initiative (HCMI), ATCC® offers a wide variety of next-generation 3-D patient-derived, comprises authenticated, fully characterized organoids derived from healthy and cancerous tissues representing a variety of physiological systems. Welcome to discuss with ours specialist for yours need, or explore ATCC® Organoids portfolios at Link